Presentation ESC 2017 Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease Presenter: Paul M. Ridker August 27, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017